Stocktoria

ADMA BIOLOGICS, INC. ADMA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2013-10-17

ADMA BIOLOGICS, INC. statistics & valuation

Market cap$2.0B
P / E13.8×
P / S4.0×
P / B4.2×
P / FCF72.9×
Net margin28.8%
Return on equity30.8%
FCF margin5.5%
Net cash$15.5M
Net debt / EBITDA-0.1×
Enterprise value USD$2.0B
EV / EBITDA10.1×
Earnings yield EBIT/EV9.5%
Return on capital34.5%
Graham number -47.6%$5.13

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($5.13); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-387.10% -164.50% -179.40% -88.50% -42.80% -10.90% 46.40% 28.80% 2018201920202020202020212022202320242025
Gross margin (%)
-148.40% -45.20% 1.40% 22.90% 34.40% 51.50% 57.40% 2018201920202020202020212022202320242025
Operating margin (%)
-354.90% -141.10% -153.80% -72.10% -25.50% 8.40% 32.60% 37.50% 2018201920202020202020212022202320242025
Return on equity (%)
-332.50% -184.30% 395.60% 449.90% -85.80% -50.80% -43.40% -20.90% 56.60% 30.80% 2018201920202020202020212022202320242025
Shares outstanding
46.4M 59.3M 86.3M 89.6M 104.9M 195.8M 221.8M 226.1M 243.3M 244.9M 2018201920202020202020212022202320242025
Net debt ($)
-$24.0M -$26.8M -$30.8M -$15.5M 2018201920202020202020212022202320242025
Share buybacks ($)
2018201920202020202020212022202320242025
Return on assets (%)
-74.00% -38.00% 158.80% 169.00% -36.50% -25.90% -18.90% -8.60% 40.50% 23.50% 2018201920202020202020212022202320242025
Free cash flow margin (%)
-381.40% -272.60% -271.70% -155.50% -47.60% 1.60% 25.90% 5.50% 2018201920202020202020212022202320242025
Debt / equity (×)
0.14× 0.00× 0.21× 0.15× 2018201920202020202020212022202320242025
EPS ($)
-$0.88 -$0.51 -$0.33 -$0.13 $0.81 $0.60 2018201920202020202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2020FY2019FY2018
Gross margin57.4%51.5%34.4%22.9%1.4%-45.2%———-148.4%
Operating margin37.5%32.6%8.4%-25.5%-72.1%-153.8%——-141.1%-354.9%
Net margin28.8%46.4%-10.9%-42.8%-88.5%-179.4%——-164.5%-387.1%
FCF margin5.5%25.9%1.6%-47.6%-155.5%-271.7%——-272.6%-381.4%
Return on assets23.5%40.5%-8.6%-18.9%-25.9%-36.5%169.0%158.8%-38.0%-74.0%
Return on equity30.8%56.6%-20.9%-43.4%-50.8%-85.8%449.9%395.6%-184.3%-332.5%
Debt / equity0.15×0.21×——————0.00×0.14×
Current ratio6.715.975.166.896.877.718.4711.106.124.63

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.